Viral Hepatitis News

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.

For the past 5 years, we have asked infectious disease clinicians to tell us when and why they chose a career in ID.

Nearly twice as many hepatitis A virus-related deaths were reported in the United States from 2016 to 2022 compared with the previous 6 years, with individuals who use drugs or experience homelessness and unstable housing most at risk.

Nearly half of infectious diseases fellowship programs were not filled on Match Day as the number of applicants declined despite an increase in certified ID programs, the Infectious Diseases Society of America announced.

We caught up with Mary Foote, MD, MPH, at IDWeek to ask how she got “Hooked on ID.”

Why ID? Cue the iconic theme music from the medical drama House.

After assessing a national cohort of U.S. veterans with chronic hepatitis B, researchers found that only about half were on antiviral therapy, although they identified some potential factors associated with lack of timely treatment.

BOSTON — The Infectious Diseases Society of America is focused on growing the ID workforce and increasing opportunities for its members, its new president told Healio at IDWeek.

IDWeek relaxed its COVID-19 policies this year, no longer requiring that attendees wear a mask or provide proof of vaccination.